ES2277139T3 - Regimen de reposicion de estrogenos. - Google Patents

Regimen de reposicion de estrogenos. Download PDF

Info

Publication number
ES2277139T3
ES2277139T3 ES03790602T ES03790602T ES2277139T3 ES 2277139 T3 ES2277139 T3 ES 2277139T3 ES 03790602 T ES03790602 T ES 03790602T ES 03790602 T ES03790602 T ES 03790602T ES 2277139 T3 ES2277139 T3 ES 2277139T3
Authority
ES
Spain
Prior art keywords
estrogen
doses
substance
exhibits
phases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES03790602T
Other languages
English (en)
Spanish (es)
Inventor
Robert Casper
Gideon Kopernik
Zeev Shoham
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2277139T3 publication Critical patent/ES2277139T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES03790602T 2002-08-28 2003-08-28 Regimen de reposicion de estrogenos. Expired - Lifetime ES2277139T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40633102P 2002-08-28 2002-08-28
US406331P 2002-08-28

Publications (1)

Publication Number Publication Date
ES2277139T3 true ES2277139T3 (es) 2007-07-01

Family

ID=31978284

Family Applications (1)

Application Number Title Priority Date Filing Date
ES03790602T Expired - Lifetime ES2277139T3 (es) 2002-08-28 2003-08-28 Regimen de reposicion de estrogenos.

Country Status (25)

Country Link
US (1) US8946198B2 (cg-RX-API-DMAC7.html)
EP (1) EP1539184B1 (cg-RX-API-DMAC7.html)
JP (1) JP2005538150A (cg-RX-API-DMAC7.html)
KR (1) KR20050059092A (cg-RX-API-DMAC7.html)
CN (1) CN1678324A (cg-RX-API-DMAC7.html)
AT (1) ATE345804T1 (cg-RX-API-DMAC7.html)
AU (1) AU2003264203A1 (cg-RX-API-DMAC7.html)
BR (1) BR0313921A (cg-RX-API-DMAC7.html)
CA (1) CA2495330A1 (cg-RX-API-DMAC7.html)
CY (1) CY1106019T1 (cg-RX-API-DMAC7.html)
DE (1) DE60309895T2 (cg-RX-API-DMAC7.html)
DK (1) DK1539184T3 (cg-RX-API-DMAC7.html)
ES (1) ES2277139T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20050291A2 (cg-RX-API-DMAC7.html)
IL (1) IL166585A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA05002294A (cg-RX-API-DMAC7.html)
NO (1) NO20051545L (cg-RX-API-DMAC7.html)
NZ (1) NZ538342A (cg-RX-API-DMAC7.html)
PL (1) PL374762A1 (cg-RX-API-DMAC7.html)
PT (1) PT1539184E (cg-RX-API-DMAC7.html)
RS (1) RS20050184A (cg-RX-API-DMAC7.html)
RU (1) RU2340345C2 (cg-RX-API-DMAC7.html)
UA (1) UA82851C2 (cg-RX-API-DMAC7.html)
WO (1) WO2004019954A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200501274B (cg-RX-API-DMAC7.html)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8617597B2 (en) 2006-07-06 2013-12-31 Bayer Intellectual Property Gmbh Pharmaceutical composition containing a tetrahydrofolic acid
DE102009007771B4 (de) 2009-02-05 2012-02-16 Bayer Schering Pharma Aktiengesellschaft Bukkales Applikationssystem, 17α-Estradiol enthaltend
EP2383279A1 (en) 2011-07-19 2011-11-02 Pantarhei Bioscience B.V. Process for the preparation of estetrol
US8951996B2 (en) 2011-07-28 2015-02-10 Lipocine Inc. 17-hydroxyprogesterone ester-containing oral compositions and related methods
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
EP2782584B1 (en) 2011-11-23 2021-06-09 TherapeuticsMD, Inc. Natural combination hormone replacement formulations and therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
MX2016011801A (es) * 2014-03-12 2017-07-14 Warner Chilcott Co Llc Crema de estradiol de dosis baja.
AR100562A1 (es) 2014-05-22 2016-10-12 Therapeuticsmd Inc Composición farmacéutica de estradiol y progesterona para terapia de reemplazo hormonal
LT3310345T (lt) 2015-06-18 2021-06-25 Estetra Sprl Burnoje disperguojama tabletė, turinti estetrolio
MA44206B1 (fr) 2015-06-18 2021-04-30 Estetra Sprl Comprimé orodispersible comprenant estetrol
EP3701944B1 (en) 2015-06-18 2021-12-08 Estetra SRL Orodispersible dosage unit containing an estetrol component
CU24523B1 (es) 2015-06-18 2021-06-08 Estetra Sprl Unidad de dosificación orodispersable que contiene un componente estetrol
JP2018522854A (ja) 2015-06-22 2018-08-16 リポカイン インコーポレーテッド 17−ヒドロキシプロゲステロンエステル含有経口組成物及び関連方法
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
KR20180126582A (ko) 2016-04-01 2018-11-27 쎄러퓨틱스엠디, 인코퍼레이티드 스테로이드 호르몬 약제학적 조성물
CA3178291A1 (en) 2016-08-05 2018-04-12 Estetra Srl Method for the management of dysmenorrhea and menstrual pain
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
EP3781171B1 (en) 2018-04-19 2022-02-09 Estetra SRL Compounds and their uses for alleviating menopause-associated symptoms
TWI893101B (zh) 2020-04-16 2025-08-11 比利時商埃斯特拉有限責任公司 具有降低之副作用之避孕組成物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826831A (en) * 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
DE19975054I2 (de) 1987-08-08 2000-04-13 Akzo Nobel Nv Kontrazeptives Implantat
US4900734A (en) * 1987-08-27 1990-02-13 Maxson Wayne S Novel pharmaceutical composition containing estradiol and progesterone for oral administration
US5256421A (en) 1987-09-24 1993-10-26 Jencap Research Ltd. Hormone preparation and method
US5276022A (en) 1987-09-24 1994-01-04 Jencap Research Ltd. Hormone preparation and method
FI101601B (fi) * 1987-09-24 1998-07-31 Jencap Res Ltd Ehkäisyvalmiste sekä estrogeenin ja progestiinin käyttö ehkäisyvalmist een valmistusmenetelmässä
US5108995A (en) 1987-09-24 1992-04-28 Jencap Research Ltd. Hormone preparation and method
US5422119A (en) 1987-09-24 1995-06-06 Jencap Research Ltd. Transdermal hormone replacement therapy
US5382873A (en) 1991-12-04 1995-01-17 U.S. Philips Corporation High-pressure discharge lamp with incandescing metal droplets
US5521166A (en) * 1994-12-19 1996-05-28 Ortho Pharmaceitical Corporation Antiprogestin cyclophasic hormonal regimen
DE19513662A1 (de) * 1995-04-08 1996-10-10 Schering Ag Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
PL181582B1 (pl) * 1995-06-07 2001-08-31 Ortho Mcneil Pharm Inc Plaster na skóre do zapobiegania owulacji u kobiety oraz plaster na skóre do przeprowadzania hormonalnej terapii substytucyjnej PL PL PL PL PL PL PL PL
US6506390B2 (en) * 1996-06-25 2003-01-14 Akzo Nobel Progestogen-anti-progestogen regimens
CA2267743C (en) * 1999-03-30 2011-07-26 Robert F. Casper Low dose estrogen interrupted hormone replacement therapy
US6653298B2 (en) * 2000-01-14 2003-11-25 Sterix Limited Composition
DE10100911A1 (de) * 2001-01-11 2002-08-01 Schering Ag Verfahren zur Hormonersatztherapie und dessen Darreichungsform

Also Published As

Publication number Publication date
HRP20050291A2 (en) 2005-10-31
BR0313921A (pt) 2005-07-19
PT1539184E (pt) 2007-02-28
CN1678324A (zh) 2005-10-05
ATE345804T1 (de) 2006-12-15
DK1539184T3 (da) 2007-03-19
ZA200501274B (en) 2006-08-30
EP1539184A1 (en) 2005-06-15
UA82851C2 (en) 2008-05-26
DE60309895D1 (de) 2007-01-04
RS20050184A (sr) 2007-11-15
PL374762A1 (en) 2005-10-31
CY1106019T1 (el) 2011-04-06
US8946198B2 (en) 2015-02-03
CA2495330A1 (en) 2004-03-11
EP1539184B1 (en) 2006-11-22
MXPA05002294A (es) 2005-09-12
WO2004019954A1 (en) 2004-03-11
IL166585A0 (en) 2006-01-15
NO20051545L (no) 2005-03-23
RU2005108977A (ru) 2005-10-10
US20060089337A1 (en) 2006-04-27
JP2005538150A (ja) 2005-12-15
RU2340345C2 (ru) 2008-12-10
KR20050059092A (ko) 2005-06-17
AU2003264203A1 (en) 2004-03-19
NZ538342A (en) 2007-08-31
DE60309895T2 (de) 2007-10-18

Similar Documents

Publication Publication Date Title
US8946198B2 (en) Estrogen replacement regimen
ES2219673T3 (es) Dosificado posologico ciclofasico de hormonas que contienen una antiprogestina y una progestina.
ES2278925T3 (es) Uso de compuestos estrogenicos en combinacion con compuestos progestogenicos en terapias de sustitucion hormonal.
US5422119A (en) Transdermal hormone replacement therapy
US8173626B2 (en) Methods, dosing regimens and medications using anti-progestational agents for the treatment of disorders
US5276022A (en) Hormone preparation and method
JP2004107353A (ja) フルベストラント製剤
PT646008E (pt) Minimizacao de hemorragias secundarias associadas a progestina
BRPI0611443A2 (pt) composição farmacêutica contendo gestágeno e/ou estrógeno e 5-metil-(6s)-tetrahidrofolato
JP2010523512A (ja) 新規ドロスピレノン/17β−エストラジオール投与計画、組み合わせ医薬、およびこの投与計画を行なうためのキット
ES2316402T3 (es) Mesoprogestagenos (moduladores de los receptores de progesterona) como un componente de composiciones para la hormonoterapia restitutiva (hrt).
Schwartz et al. Effects of various replacement oestrogens on hepatic transcortin synthesis in climacteric women
BR102024026566A2 (pt) Sistema de entrega de fármacos para combinações de estrogênio em dose ultrabaixa e métodos e usos deste
AU3662300A (en) Use of sex hormones to obtain a nasal pharmaceutical composition that is useful in the treatment of undesirable uterine bleeding
SK25299A3 (en) Transdermal therapeutical approach involving a combination of active substances containing oestriol
SI9300687A (en) Transdermal hormone replacement therapy
JPH0692856A (ja) エストリオールの高血中濃度が得られる軟膏剤
HK1084018A (en) Estrogen replacement regimen
MXPA01008772A (en) Use of sex hormones to obtain a nasal pharmaceutical composition that is useful in the treatment of undesirable uterine bleeding